Zomedica Statistics
Total Valuation
Zomedica has a market cap or net worth of 49.05 million. The enterprise value is -20.49 million.
Market Cap | 49.05M |
Enterprise Value | -20.49M |
Important Dates
The last earnings date was Thursday, March 13, 2025.
Earnings Date | Mar 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Zomedica has 979.95 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 979.95M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 0.73% |
Owned by Institutions (%) | 9.34% |
Float | 961.66M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.80 |
PB Ratio | 0.25 |
P/TBV Ratio | 0.50 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 0.44 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | 0.71 |
Financial Position
The company has a current ratio of 8.76, with a Debt / Equity ratio of 0.01.
Current Ratio | 8.76 |
Quick Ratio | 7.98 |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | -0.06 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -21.57% and return on invested capital (ROIC) is -9.95%.
Return on Equity (ROE) | -21.57% |
Return on Assets (ROA) | -9.51% |
Return on Invested Capital (ROIC) | -9.95% |
Return on Capital Employed (ROCE) | -17.69% |
Revenue Per Employee | 189,479 |
Profits Per Employee | -326,264 |
Employee Count | 144 |
Asset Turnover | 0.12 |
Inventory Turnover | 1.61 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -64.03% in the last 52 weeks. The beta is 1.16, so Zomedica's price volatility has been higher than the market average.
Beta (5Y) | 1.16 |
52-Week Price Change | -64.03% |
50-Day Moving Average | 0.11 |
200-Day Moving Average | 0.13 |
Relative Strength Index (RSI) | 30.24 |
Average Volume (20 Days) | 13,814,343 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Zomedica had revenue of 27.29 million and -46.98 million in losses. Loss per share was -0.05.
Revenue | 27.29M |
Gross Profit | 19.09M |
Operating Income | -35.03M |
Pretax Income | -47.54M |
Net Income | -46.98M |
EBITDA | -27.04M |
EBIT | -35.03M |
Loss Per Share | -0.05 |
Balance Sheet
The company has 71.35 million in cash and 1.81 million in debt, giving a net cash position of 69.54 million or 0.07 per share.
Cash & Cash Equivalents | 71.35M |
Total Debt | 1.81M |
Net Cash | 69.54M |
Net Cash Per Share | 0.07 |
Equity (Book Value) | 195.66M |
Book Value Per Share | 0.20 |
Working Capital | 72.44M |
Cash Flow
In the last 12 months, operating cash flow was -23.63 million and capital expenditures -5.21 million, giving a free cash flow of -28.84 million.
Operating Cash Flow | -23.63M |
Capital Expenditures | -5.21M |
Free Cash Flow | -28.84M |
FCF Per Share | -0.03 |
Margins
Gross margin is 69.95%, with operating and profit margins of -128.38% and -172.19%.
Gross Margin | 69.95% |
Operating Margin | -128.38% |
Pretax Margin | -174.23% |
Profit Margin | -172.19% |
EBITDA Margin | -99.11% |
EBIT Margin | -128.38% |
FCF Margin | n/a |
Dividends & Yields
Zomedica does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -95.79% |
FCF Yield | -58.81% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |